Ocular Therapeutix, Inc. (OCUL) vs DENTSPLY SIRONA Inc. (XRAY)

A side-by-side comparison of Ocular Therapeutix, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OCUL vs XRAY

growth of $100 · dividends reinvested · last 10y
OCUL +12.9% (+1.2%/yr)XRAY -83.3% (-16.4%/yr)OCUL compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020182020202220242026$113$17
OCUL XRAY

OCUL vs XRAY: by the numbers

  • •XRAY is the larger company ($1.72B vs $1.62B market cap).
  • •Both run net losses; XRAY's is the smaller (-14.99% vs -579.10% net margin).
  • •OCUL grew revenue faster over the past five years (10.03% vs 1.96% CAGR).
  • •XRAY pays a dividend (3.74% yield), while OCUL has no payments in the available dividend history.

Metrics side by side

Valuation

MetricOCULXRAY
Forward P/EN/A5.64
P/S ratio31.180.47
P/B ratio3.121.27
EV / EBITDAN/A4.44
FCF yieldN/A8.30%

Profitability

MetricOCULXRAY
Gross margin87.11%49.52%
Operating margin-521.04%11.69%
Net margin-579.10%-14.99%
ROE-57.97%-40.41%
ROIC-50.20%10.03%

Dividends

MetricOCULXRAY
Dividend yieldN/A3.74%

Growth (annualized)

MetricOCULXRAY
Revenue CAGR (5Y)10.03%1.96%
FCF CAGR (5Y)N/A-25.74%
Total return CAGR (5Y)-5.73%-30.27%

Frequently asked

Which has grown faster, OCUL or XRAY?
Over the past five years, OCUL grew revenue faster — OCUL at a 10.03% CAGR versus XRAY at 1.96%.
Does OCUL or XRAY pay a bigger dividend?
XRAY pays a dividend (3.74% yield), while OCUL has no payments in the available dividend history.
How have OCUL and XRAY total returns compared?
Over the past 10 years, OCUL delivered 0.44% and XRAY delivered -16.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.